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Abstract
Background: Alpha synuclein (a-Syn) is the main component of Lewy bodies which are associated with several
neurodegenerative diseases such as Parkinson’s disease. While the glycation with D-glucose that results in a-Syn misfold
and aggregation has been studied, the effects of glycation with D-ribose on a-Syn have not been investigated.
Methodology/Principal Findings: Here, we show that ribosylation induces a-Syn misfolding and generates advanced
glycation end products (AGEs) which form protein molten globules with high cytotoxcity. Results from native- and SDS-
PAGE showed that D-ribose reacted rapidly with a-Syn, leading to dimerization and polymerization. Trypsin digestion and
sequencing analysis revealed that during ribosylation the lysinyl residues (K58,K 60,K 80,K 96,K 97 and K102) in the C-terminal
region reacted more quickly with D-ribose than those of the N-terminal region. Using Western blotting, AGEs resulting from
the glycation of a-Syn were observed within 24 h in the presence of D-ribose, but were not observed in the presence of D-
glucose. Changes in fluorescence at 410 nm demonstrated again that AGEs were formed during early ribosylation. Changes
in the secondary structure of ribosylated a-Syn were not clearly detected by CD spectrometry in studies on protein
conformation. However, intrinsic fluorescence at 310 nm decreased markedly in the presence of D-ribose. Observations with
atomic force microscopy showed that the surface morphology of glycated a-Syn looked like globular aggregates. thioflavin
T (ThT) fluorescence increased during a-Syn incubation regardless of ribosylation. As incubation time increased, ribosylation
of a-Syn resulted in a blue-shift (,100 nm) in the fluorescence of ANS. The light scattering intensity of ribosylated a-Syn
was not markedly different from native a-Syn, suggesting that ribosylated a-Syn is present as molten protein globules.
Ribosylated products had a high cytotoxicity to SH-SY5Y cells, leading to LDH release and increase in the levels of reactive
oxygen species (ROS).
Conclusions/Significance: a-Syn is rapidly glycated in the presence of D-ribose generating molten globule-like
aggregations which cause cell oxidative stress and result in high cytotoxicity.
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Introduction
Alpha-synuclein (a-Syn), a protein located in the cytoplasm
which contains 140 amino acids, is a member of a highly
conserved family of proteins consisting of a-, b-, and c-synuclein.
a-Syn, an abundant neuronal protein involved in synaptic
function, has become extremely important in studies on the
pathology of several common neurodegenerative diseases, includ-
ing Parkinson’s disease (PD), dementia characterized by the
presence of Lewy bodies (LB), and multiple system atrophy
[1,2,3,4,5]. The prominence of a-Syn in LB in the substantia nigra
is one of the cardinal pathological features of PD [6]. PD is a
chronic, progressive movement disorder, with four primary
symptoms: tremor, bradykinesia, rigidity and postural instability.
After Alzheimer’s disease, PD is the most common neurodegen-
erative disorder, with an estimated lifetime risk of approximately 1
in 100 persons [7]. While the native protein is naturally unfolded
under physiological conditions, the a-Syn protein in Lewy bodies
from brain tissues of PD patients is misfolded and becomes
protease-resistant [8]. Many research groups have found that
chemical modifications such as glycation [9], sumoylation [10],
and phosphorylation [11] are involved in a-Syn misfolding and
aggregation.
In recent years the glycation of a-Syn in Lewy bodies has
become one of important problems in this field. Many authors
have suggested that glycation of a-Syn is a pathological hallmark
of LB in PD patients [9,12,13]. Advanced glycation end-products
(AGEs) and a-Syn are co-localized in the brain of the patients at
both the early and advanced stages of PD [9]. The intracellular
accumulation of AGEs precedes a-Syn-positive inclusion body
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9052formation, and extracellular AGEs accelerate the process of
intracellular a-Syn-positive inclusion body formation [12].
So far, although glycation of a-Syn has received considerable
attention, the role of D-ribose in glycation has not been studied. D-
ribose is a naturally occurring pentose monosaccharide present in
all living cells (also in blood) and is an essential component for
biological energy production. Seuffer has determined the concen-
tration of D-ribose (0.01–0.1 mM) present in cerebrospinal fluid
(CSF) [14]. It is used to synthesize nucleotides, nucleic acids,
glycogen, and other important metabolic products. D-ribose is also
formed in the body from conversion of D-glucose via the pentose
phosphate pathway. Thus, D-ribose is present both intracellularly
and extracellularly, and has opportunities to react with proteins
and produce glycated derivatives. For this reason, glycation of a-
Syn protein with D-ribose needs to be investigated.
Glycation affects the conformation and function of proteins such
as hemoglobin [15] and albumin [16,17], leading to a marked loss
of their functions [18]. Abnormal modification, including glyca-
tion, induces neuronal proteins to misfold and form amyloid fibrils
in a stepwise process from prefibrils to fibrils [19]. More research is
needed to elucidate abnormal modifications such as glycation
which play an important role in the aggregation and toxicity of a-
Syn [6]. The significance of a-Syn fibrillization in PD is supported
by a growing body of evidence. Insoluble a-Syn is the major
component of Lewy bodies, cytoplasmic intraneuronal inclusions
that are the defining neuropathological feature of PD [1,20].
Dobson and colleagues report that only globular, pre-fibrillar
aggregates display cytotoxicity, whereas mature fibrils are substan-
tially harmless [21,22]. Globule-like protein aggregations (pro-
amyloid fibrils) are highly toxic to neurons [21,23,24,25,26].
Recently, formation of molten globule-like states has been reported
during prolonged glycation of human serum albumin [27]. However,
there are no reports in the literature that glycation with D-ribose
induces protein misfolding into molten globules during aggregation.
The characteristics and cytotoxicity of molten globule-like protein
states induced by either D-riboseorD-glucosehavenotbeenclarified.
In this laboratory, we have observed that glycation induces
inactivation and conformational change in D-glyceraldehyde-3-
phosphate dehydrogenase [28,29]. While in vitro glycation of a-Syn
with D-glucose does not result in distinct conformational changes of the
protein [30], ribosylation of bovine serum albumin (BSA) and neuronal
Tau protein leads to ThT-positive aggregations with high cytotoxicity
[31,32]. We have also found that Tau protein aggregates in the
presence of formaldehyde at low concentrations and forms ThT-
positive deposits which are cytotoxic [33]. Here, we investigate the
sequential order of ribosylation of lysinyl residues of a-Syn and whether
it generates cytotoxic molten globule-like aggregations.
Results
Ribosylation of Alpha-Synuclein
Recombinant human a-synuclein was expressed in E. coli cells
and purified by a stepwise procedure as described in the Materials
and Methods. The a-Syn protein ran as a single band on 15%
SDS-PAGE with a purity of ,95% (Fig. S1). The purified a-Syn
protein was confirmed by Western blotting with a monoclonal
antibody (data not shown).
During ribosylation, we incubated a-Syn with D-ribose and took
aliquots at different time intervals for electrophoretic SDS-PAGE
and native PAGE (Fig. 1). Protein dimerization began around day
Figure 1. Ribosylated a-Syn on native-PAGE and SDS-PAGE. 0.7 mM a-Syn was incubated with 1 M D-ribose (A) and 1 M D-glucose (B) for 0–7
days, and then loaded on 15% native-PAGE (left) and 15% SDS-PAGE (right) gels. (C) Native a-Syn alone was used as a control.
doi:10.1371/journal.pone.0009052.g001
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a-Syn was not detected in the presence of D-glucose (Fig. 1B) or in
the absence of sugar (Fig. 1C). Analysis using mass spectrometry
showed that the molecular mass of glycated a-Syn (incubated for 7
days) increased to ,16,297 Da, about 1,848 Da higher than that
for native a-Syn, indicating that, on average about 14 ribosyl
groups (132 Da each) were bound to a-Syn.
According to Liu and colleagues [34], glycation of a protein
produces a new fluorescence derivative (lex320 nm, lem410 nm),
and thus fluorescence is commonly used to monitor the formation
of AGEs. As shown in Fig. 2A, the fluorescence emission intensity
of a-Syn incubated with D-ribose (a-Syn + rib) for 7 days was
much stronger than for that incubated with D-glucose (a-Syn +
glc). a-Syn alone, used as a negative control, showed no
fluorescence at 410 nm. To characterize whether the fluorescence
at 410 nm resulted from the reaction of D-ribose with lysinyl
residues, we resuspended lysine in a D-ribose solution under the
experimental conditions, and observed a strong fluorescent
emission at 425 nm by excitation at 320 nm (Fig. 2B). Native a-
Syn, lysine and D-ribose did not show marked fluorescence. This
suggests that the fluorescent derivative is resulted from the reaction
of D-ribose with e-amino groups of the lysinyl residues of the
protein.
To confirm whether AGEs were formed during glycation with
D-ribose, a monoclonal antibody that is commonly used to assay
AGEs (6D12) was used in Western blotting [35]. The monoclonal
antibody recognized both monomers and dimers of the glycated
protein from day 1 to day 7 of the incubation. a-Syn in the
presence of D-glucose or absence of sugar did not show significant
spots on the membrane under the experimental conditions (not
shown). Thus our results suggest that AGEs resulting from
ribosylated a-Syn start to form at the initial stage of the incubation
(Fig. 3A).
Kinetics of Ribosylation
Changes in the fluorescence at 410 nm at different time
intervals (days) were measured. The emission intensity of
ribosylated a-Syn increased markedly with incubation time
(Fig. 2C). But glucosylated and native a-Syn did not show marked
increases in the fluorescence under the experimental conditions
used in this study. This demonstrates that glycation of a-Syn with
D-ribose occurs much more rapidly than that with glucose.
Fructosamine is a common product of glycation and the
fructosamine content of a given protein reflects its degree of
glycation [36,37]. The assay of fructosamine with nitroblue
tetrazolium (NBT) is based on a color change correlated with
the reduction of NBT to monoformazan by Amadori rearrange-
ment products in an alkaline buffer. Here, we used NBT to
monitor the time course of formation of fructosamine during
glycation. As shown in Fig. 3B, the absorbance at 540 nm
increased markedly with time. The absorption value increased
rapidly on day 1 and then gradually reached a plateau. Analysis of
the yield of fructosamine on day 7 of the incubation showed that
about 15 moles of D-ribosyl groups and 8 moles of D-glucosyl
groups were coupled with one mole of a-Syn.
Kinetic studies showed that the increase in the absorbance at
540 nm (formation of fructosamine) underwent a monophasic time
course with a first order rate constant of 5.79610
26?s
21 for
ribosylated a-Syn, while the first order rate constant was
1.33610
26?s
-1 for glucosylated a-Syn (Table 1). This suggests that
ribosylation of a-Syn occurs much faster than glucosylation.
In order to observe the time course of ribosylation of lysinyl
residures, we used trypsin (which specifically recognizes lysinyl
residues) to digest ribosylated a-Syn (Fig. 4A) Ribosylated a-Syn
became resistant to trypsin digestion (mass ratio of ribosylated a-
Syn to protease: 20:1). On day 1 of the incubation, one protein
band (apparent molecular mass ,12.8 KDa) appeared on SDS-
PAGE gels, followed by another digested band (apparent
molecular mass ,18.4 KDa) on day 3. The density of the
ribosylated a-Syn band became thicker as incubation time
increased. In contrast, native a-Syn was rapidly degraded under
the experimental conditions used (Fig. 4B). Ribosylation blocked
the cleavage sites which trypsin recognized. According to sequence
analysis, trypsin cleaved at K43-T44 and K45-E46 released the
Figure 2. Changes in fluorescence during protein riboslyation.
Glycation conditions were the same as those in Fig. 1. (A) Aliquots were
taken for measurements of the intrinsic fluorescence at an excitation
wavelength of 320 nm after incubation for 3 days. (B) Characteristics of
the fluorescence of glycated products. (C) Changes in the maximal
fluorescent intensity (lex320 nm; lem410 nm) were monitored while a-
Syn was incubated with D-ribose, or glucose for different time intervals.
doi:10.1371/journal.pone.0009052.g002
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K12-E13 produced the ,18.4 KDa fragment detected by SDS-
PAGE (Fig. 4C and Fig. S2). This indicates that the a-amino
groups of the lysinyl residues (K58,K 60,K 80,K 96,K 97 and K102)i n
the C-terminal region were more rapidly ribosylated than those
(K6,K 10,K 12,K 21,K 23,K 32,K 34,K 43 and K45) in the N-terminal
region.
Conformational Changes of Ribosylated Alpha-Syn
Although human a-Syn is known to be a natively unfolded
protein [38], we wanted to determine whether the secondary
structure of a-Syn changes during ribosylation. As shown in Fig. 5,
a-Syn has a far-UV CD spectrum typical of an unfolded
polypeptide chain. The spectrum of ribosylated a-Syn was almost
the same as that of native a-Syn indicating that the secondary
structures of ribosylated a-Syn do not undergo significant changes.
Similar to native a-Syn, the modified protein lacked ordered
secondary structures under the experimental conditions used.
To investigate whether ribosylation induced a change in the
tertiary structure of a-Syn, we took aliquots at different incubation
time intervals and measured the protein intrinsic fluorescence (at
310 nm, arising from tyrosinyl residues). As shown in Fig. 6A, the
intensity of intrinsic fluorescence decreased when a-Syn was
incubated with D-ribose at different concentrations. In the time
course study (Fig. 6B), the emission intensity of the protein intrinsic
fluorescence decreased with time, especially on day 1 of the
incubation. Under the experimental conditions used here, changes
in the intrinsic fluorescence of a-Syn incubated with D-glucose
were not marked, as was the case for native a-Syn in the absence
of sugar. It appears that there may be changes in the tertiary
structure of a-Syn during ribosylation.
In kinetic studies, changes in the intensity of intrinsic
fluorescence decreased and underwent a biphasic procedure: a
fast and slow phase (Table 1). The first order rate constant of the
fast phase was 19.04610
26?s
21, showing a rapid change in the
tertiary structure at the initial stage of ribosylation, followed by a
relatively slow change.
Fig. 6C shows us an interesting result. Fluorescence at around
440 nm appeared with ribosylated a-Syn with an excitation
wavelength of 280 nm (the excitation wavelength for detecting the
intrinsic fluorescence of tyrosinyl residues). The emission intensity
increased during the glycation process, accompanied with a blue
shift from 450 nm to 440 nm, indicating that an energy transfer
occurred between the tyrosinyl residues and the ribosylated
groups, and confirming that the ribosylated groups are spatially
close to the tyrosinyl residues within the protein.
The fluorescent molecule 8-anilino-1-naphthalenesulfonate
(ANS), which is frequently used to demonstrate the presence of
partially folded conformations of globular proteins [39], was used
to clarify whether any hydrophobic patches become exposed to the
exterior of the a-Syn molecule. Fig. 7A shows that ribosylation
increased the ANS fluorescence intensity (525 nm) and induced a
blue shift (,100 nm) of the ANS lmax. Under the same conditions,
little blue shift was observed with native a-Syn in the absence of D-
ribose (Fig. 7B). These results show that a-Syn is converted into a
partially folded conformation with solvent-exposed hydrophobic
patches present within protein molten globules during ribosylation.
Ribosylated a-Syn in Molten Globules
To investigate the occurrence of protein molten globules,
atomic force microscopy (AFM) was employed to observe glycated
a-Syn. As shown in Fig. 8A, globule-like aggregates of ribosylated
a-Syn (3 days) were numerous under AFM using the tapping
model in air. The average height of glycated a-Syn was
19.2260.71 nm. Globular aggregates were not present in control
samples of native a-Syn, however some surface irregularities on
the mica surface with a height of 3.7760.38 nm were observed
(Fig. 8B, D). Globule-like forms were not observed when D-ribose
alone was employed as a control (Fig. 8C). This suggests that
ribosylated a-Syn is polymerized and exists in molten globules.
The fluorescence emission of thioflavin T, a specific fluorescent
marker for intermolecular b-sheets (amyloid-like aggregates), is often
used to clarify the characterization of protein aggregates [40,41].
Here we employed ThT to investigate the intermolecular b-sheets in
ribosylated a-Syn polymers [42]. ThT fluorescence (lex 450 nm, lem
485 nm) was slightly increased during the ribosylation of a-Syn as
shown in Fig. 9A. However, the intensities of the ThT fluorescence of
ribosylated a-Syn were similar to those of native a-Syn incubated in
the absence of D-ribose. Furthermore, the emission intensities of the
protein in the presence of D-ribose at different concentrations were
Figure 3. Detection of AGEs by Western blotting and NBT
assays. The glycation conditions of a-Syn were the same as those in
Fig. 1. (A) Western blotting of the aliquots (ribosylated a-Syn) with anti-
AGEs was performed at different time intervals. (B) Fructosamine was
assayed with NBT. (C) Data in panel B were analyzed according to Tsou’s
method [74].
doi:10.1371/journal.pone.0009052.g003
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characteristic of aggregation further suggests that ribosylated a-Syn
molecules exist in molten globules.
To further confirm that ribosylated a-Syn exists as molten
globules, light-scattering of the sample solutions was measured
(Fig. 9B). Light-scattering intensities (480 nm) did not show a
significant change between ribosylated and native a-Syn until day
7 of the incubation, indicating that both were soluble in solution,
although glycation induced protein dimerization and polymeriza-
tion. This further suggests that the dimers and polymers of
ribosylated a-Syn were in molten globular states under the
experimental conditions employed.
Figure 4. Digestion of glycated a-Syn in the presence of trypsin. (A) Aliquots were digested by trypsin at a mass ratio [a-Syn]/[trypsin] of 20:1
(37uC, 1 h). (B) Native a-Syn alone was used as a control. (C) a-Syn amino acid sequence. The protein fragments ‘a’ and ‘b’ as shown in panel A were
sequenced as described [75]. Lysine residues are shown in green, except those at the cleavage sites (as determined by sequencing) which are shown
in red.
doi:10.1371/journal.pone.0009052.g004
Table 1. First order rate constants for changes in fructosamine and fluorescence during the glycation of a-Syn protein in the
presence of D-ribose or D-glucose.
Kinetic measurements Relaxation time (h) First phase Second phase
Grey density Monomer Oligomer – 24 – 5.67 – 1.48
Fructosamine (a-Syn+rib) – 5.79 –
Fructosamine (a-Syn+glc) – 1.33 –
Fluorescence at 310 nm – 19.04 7.11
Fluorescence at 410 nm 24 3.03 16.70
ThT fluorescence(a-Syn) 24 1.90 7.01
ThT fluorescence(a-Syn+rib) – 2.13 7.01
Rate constants are in 10
26.
doi:10.1371/journal.pone.0009052.t001
Ribosylated a-Synuclein
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Cytotoxicity
Since ribosylated a-Syn is present as molten globules, its
cytotoxicity is a matter of great concern. The effect of ribosylated
a-Syn on the viability of SH-SY5Y cells was examined using MTT
assays (Fig. 10). The number of viable cells decreased significantly
when they were incubated with ribosylated a-Syn for 8 h, while
cell viability did not significantly change in the presence of native
a-Syn or D-ribose. The reduction in cell viability induced by
ribosylated a-Syn was affected in a concentration dependent
manner at different time intervals (24, 48 and 72 h).
In order to reveal the cause of the reduction in cell viability
induced by glycated a-Syn, annexin V/PI assays were examined
on a flow cytometer (Fig. 11). After incubation with ribosylated a-
Syn for 8 h, a significant increase in early apoptosis (LR, 9.13%)
and late apoptosis/necrosis (UR, 77.31%) rates were observed
(Fig. 11D), while the ratios were lower than 3% (LR) and 6% (UR)
in the presence of native a-Syn, D-ribose and untreated control
cells (Fig. 11C, B, A). These results indicate that ribosylated a-Syn
induces cell apoptosis and necrosis.
To confirm that cells are damaged in the presence of ribosylated
a-Syn, release of LDH from the SHSY5Y cells was measured
(Fig. 12A). Glycated a-Syn at high concentration (35 mM) was able
to trigger cell death in 8 h of incubation, however, native a-Syn or
D-ribose alone did not show significant cytotoxicity at the same
concentrations. These results reveal that molten globules of
ribosylated a-Syn have high cytotoxicity and induce apoptosis
and necrosis of cells.
More interestingly, in order to determine whether free radicals
are involved in SHSY5Y lesions, the level of intracellular reactive
oxygen species (ROS) was measured (Fig. 12B). After SHSY5Y cells
were incubated with ribosylated a-Syn for 8 h, the level of ROS
increased significantly in comparison to cells which were incubated
withnative a-SynorD-ribose alone.Thissuggeststhat theincreased
level of intracellular ROS is involved in the cytotoxicity.
Discussion
a-synuclein is vulnerable to aggregation under pathological
conditions and forms insoluble fibrils that are a characteristic of
Lewy bodies, a pathological hallmark of the neurodegenerative
diseases. According to recent studies [21,43], globule-like protein
aggregations are significantly toxic to neural cells. In addition to
posttranslational modifications such as phosphorylation [44], and
sumoylation [13], glycation is commonly regarded as a cause of
disrupted protein function and produces cytotoxic products such
as AGEs, leading to medical complications [45,46]. Our results
have shown that a-Syn protein is rapidly glycated and induced to
form globule-like aggregations in the presence of D-ribose. Here
we have investigated whether ribosylation of a-Syn yields protein
molten globules with ThT-positive characteristics and high
cytotoxicity to SHSY5Y cells.
Figure 5. Changes in the CD spectra of a-Syn in the presence of
D-ribose. A representative CD spectra of a-Syn incubated with D-
ribose (day 3) is shown. Conditions for glycation of a-Syn with D-ribose
were the same as those in Fig. 1.
doi:10.1371/journal.pone.0009052.g005
Figure 6. Conformational changes in glycated a-Syn observed
by intrinsic fluorescence. Experimental conditions were the same as
those in Fig. 1. (A) Fluorescence spectra of a-Syn glycated with D-ribose
at an excitation wavelength of 280 nm. (B) The kinetics of fluorescence
in D-ribose glycated with a-Syn was analyzed at different time intervals
(lex 280 nm; lem 310 nm). (C) The incubation time-dependent increase
in non tryptophan fluorescence is shown for 0 to 7 days.
doi:10.1371/journal.pone.0009052.g006
Ribosylated a-Synuclein
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As is the case with glucosylation, ribosylation occurs between
the amino groups of a protein, particularly between the epsilon
amino groups of lysinyl residues. Such carbohydrate-amino acid
reactions, often termed as ‘‘maillard’’ or ‘‘non-enzymatic brown-
ing’’ reactions, result in linkages that are not hydrolyzed by
digestive enzymes although the amino acids may still be recovered
from the protein by acid hydrolysis [47]. Histidinyl and
tryptophanyl residues also react in this way but do so much more
slowly with reducing sugars. The argininyl residue is also able to
react with D-ribose, but a-Syn does not contain this residue.
As an efficient glycating agent, D-ribose is a naturally occurring
pentose monosaccharide and an essential component for energy
production in the human body. D-ribose is present in all living cells
and blood, and is present in the human brain [48] as well as in
CSF [14]. Moreover, a-Syn has an unstable conformation with a
flexible peptidyl chain. Weinreb and colleagues showed that the a-
Syn protein exists in a native ‘‘unfolded’’ conformation, having an
irregular structures [49]. Most lysinyl residues are probably
exposed to the exterior of the a-Syn molecule because of the
hydrophilic nature of the e-amino group. The ‘‘worm-like’’
conformation of the a-Syn protein, whose lysinyl residues are
exposed, creates more opportunities for reactions with reducing
sugars than does the conformation of globular proteins, explaining
why a-Syn is rapidly glycated in the presence of D-ribose.
Our mass spectrometry results suggest that approximately 14 D-
ribosyl groups bind to one molecule of a-Syn protein. Results from
NBT assays described above are not as precise as that of mass
spectrometry. As a-Syn contains 15 lysinyl residues, we suggest
that most of the lysinyl residues are available and can react with D-
ribose. As shown in Fig. 4, D-ribose reacts first with the e-amino
groups of lysinyl residues in the C-terminal region (K58,K 60,K 80,
K96,K 97,K 102 and a-amino group), and then with the K6,K 10,
K12,K 21,K 23,K 32,K 34,K 43 and K45 groups of the N-terminal
region. A possible order for ribosylation of the a-Syn protein is
shown in Fig. 13. That is, ribosylation of a-Syn undergoes a rapid
modification in the C-terminal lysinly residues and a slow
modification in the N-terminal region, accompanied with protein
aggregation.
D-Ribose and Glucose in Glycation of a-Syn
So far, however, most research groups have been studying
glycation with D-glucose rather than D-ribose even though D-
ribose is present both intracellularly and extracellularly. One
hand, according to, e.g. Mak et al. [50], the CSF glucose
concentration is about 4 mM, i. e. 40–400 times higher than the
ribose concentrations. Thus, in brain glucose appears to be much
more abundant than ribose. On the other hand, D-glucose has a
much lower reducing potential than that of D-ribose. We have
previously shown that glycation of a-Syn with D-glucose is a slow
procedure, and glucosylated a-Syn had no significant cytotoxicity
under the experimental conditions [30]. Glycation of BSA with D-
ribose is much faster than that with D-glucose [31]. Even though
the concentration of D-ribose is 10 times lower than that of
glucose, ribosylation is still much faster that glucosylation. This is
due to the low glycation efficiency of D-glucose compared with D-
ribose. However, it is still unclear whether D-glucose is the most
important sugar in a-Syn glycation in vivo although AGEs and a-
Syn have been found in Lewy bodies. Whether the sugar on the
glycated a-Syn is ribose or not has not been confirmed in the
literature. Although it is shown here that ribose reacts faster with
alpha-synuclein in vitro, glucose that might be quantitatively more
relevant in vivo for AGE formation and alpha-synuclein
pathogenesis should be further investigated.
We postulate that ribosylation of a-Syn is more efficient than
glucosylation based on the following observations: (1) The
formation of 410 nm fluorescence in ribosylation was faster than
that in glucosylation as shown in Fig. 2A; (2) the NBT assay
showed that glycation of a-Syn with D-ribose was faster and
produced more fructosamine than with D-glucose (Fig. 3B); (3)
The first order rate constant for changes in the intrinsic
fluorescence of a-Syn in the presence of D-ribose was greater
than that in the presence of D-glucose as shown in our previous
work [30]; and finally, (4) the cytotoxicity of ribosylated a-Syn
(20 mM in MTT and LDH assays) is distinctly stronger than for
glucosylated a-Syn (data not shown).
Ribosylation of a-Syn Promotes Molten Globules
According to previous reports, it is still unclear whether
glycation with D-glucose can induce a-Syn protein to form
amyloid aggregates. Here, however, we have shown that D-ribose
reacted quickly with a-Syn to promote aggregation of glycated
products into ThT-positive aggregates (Fig. 9A). Fibrils were not
observed under the experimental conditions. In particular, the first
Figure 7. Changes in ANS fluorescence of a-Syn during
glycation. Experimental conditions were the same as those in Fig. 1.
(A) ANS (70 mM) was added to samples of ribosylated a-Syn at different
time intervals. Fluorescence spectra of ANS were recorded at lex 350
nm. (B) Native a-Syn alone was used as a control.
doi:10.1371/journal.pone.0009052.g007
Ribosylated a-Synuclein
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fluorescence was rapid from day 5 of glycation, and paralleled a
decrease in the intrinsic fluorescence of the a-Syn protein. Under
AFM, the ribosylated aggregates looked like globules on the mica
surface. Fibrils of ribosylated a-Syn could not be observed on the
mica diaphragm under our experimental conditions (Fig. 8A).
Thus glycation with D-ribose induces the a-Syn protein to form
globular aggregations.
Molten globules of a protein are one of the early intermediate
states of protein misfolding [51,52]. We conclude that ribosylated
a-Syn is present as molten globules based on these observations. (1)
As mentioned above, the far-UV CD spectra (Fig. 5) showed little
change in the secondary structures of the protein. Similar results
have been observed during glycation of albumin, in which the far-
UV CD of the glycated protein was not significantly changed
compared with that of the native albumin used as a control [17].
(2) The intrinsic fluorescence of a-Syn with D-ribose changed
markedly during the incubation period, suggesting a distinct
conformational change in the tertiary structure [53,54]. (3) The
positive results of the ANS assay reveal the exposure of some
hydrophobic patches of the ribosylated a-Syn protein molecules,
another piece of evidence indicating the molten globule state [55].
(4) We have not observed the formation of amyloid-fibrils with
ribosylated a-Syn under the experimental conditions used. (5) We
have observed that ribosylated a-Syn is present as globular-like
aggregations on the mica diaphragm using AFM. (6) The intensity
of the light scattering of ribosylated a-Syn samples did not
markedly increase until day 7 of the incubation, suggesting that the
glycated protein is soluble in solution, namely that it is present as
molten globules.
a-Syn Molten-Globules Are Characteristic of AGEs
Glycation is a non-enzymatic post-translational modification
that involves a covalent linkage between a sugar and an amino
group of a protein forming a ketoamine [56]. Subsequent
oxidation, fragmentation and/or cross-linking of ketoamines lead
to the production of AGEs [57,58]. AGEs are thought to play an
important role in PD by oxidation of a-Syn. The AGE formation
has detrimental effects on the structure and function of affected
proteins [59]. Accumulation of AGEs has been implicated in
normal aging and in the pathogenesis of diabetes-associated
complications and PD. In the case of ribosylated a-Syn, the highly
cytotoxic glycated products appear to result from globular
aggregations of AGEs. Anti-AGE monoclonal antibodies recog-
nized both glycated monomers and glycated dimers; that is, AGEs
could be monomers, dimers and polymers of ribosylated a-Syn.
Cytotoxicity of ribosylated a-Syn was marked under the
experimental conditions employed (Fig. 10 and Fig. 12A),
suggesting that molten globules of a-Syn have high cytotoxicity.
Appearance of fluorescence at 410 nm has been observed
during the incubation of a-Syn with D-ribose (Fig. 2). This
fluorescence is thought to be diagnostic for AGEs resulting from
glycation [34,60,61,62]. The presence of this fluorescence shows
that AGE-dimerization and AGE-polymerization of a-Syn occur,
because (1) the ribosylated a-Syn dimer appears in the early stages
of glycation as shown by SDS-PAGE (Fig. 1); (2) globular
Figure 8. Glycated a-Syn deposits were imaged by atomic force microscopy. (A) Aliquots of a-Syn incubated with D-ribose for three days
were taken for observation by AFM. (B) Native a-Syn was employed as a control. (C) D-Ribose alone was used as a negative control. (D) Horizontal
diameter at mid-height.
doi:10.1371/journal.pone.0009052.g008
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(Fig. 8); (3) the kinetic increase in the intrinsic fluorescence is a
biphasic process (with a fast-slow phase) similar to that of
dimerization of the glycated protein; and (4) the increase in the
410 nm fluorescence underwent a slow-fast phase that is similar to
that of ThT fluorescence (Table 1).
It is interesting, however, that during glycation a new
fluorescence appears at around 450 nm after excitation at 280
nm (Fig. 6C). According to Matiacevich and colleagues [60], this
most likely represents the formation of AGEs. Our results showed
the energy transfer between the intrinsic fluorophore (tyrosinyl
residues) and the glycated fluorescent derivatives. The intrinsic
fluorescence of tyrosinyl residues around 310 nm was absorbed by
the glycated fluorescent derivatives and emitted at 450 nm. This
evidence shows that the glycated fluorescent derivatives are
spatially close to the tyrosinyl residues in ribosylated a-Syn dimers
and polymers.
Ribosylation of Proteins Case by Case
In general, ribosylation of different proteins has some common
characteristics: formation of globule-like protein aggregations
(molten globules), and production of AGEs with high cytotoxicity.
However, different proteins undergo different changes in their
conformational features. Dimerization of the a-Syn protein clearly
occurs as shown by the ribosylation on SDS-PAGE, but polymers
are not stable (as shown by native-PAGE, Fig. 1). For neuronal
Tau protein, the monomer, oligomer and polymer are present and
can be seen to follow a clear ribosylation procedure on SDS-
PAGE [32]. For BSA, a glycated monomer is present, while
ribosylated dimers and polymers cannot be clearly detected on
SDS-PAGE [31]. Thus, although D-ribose initially reacts with an
amino group of a protein undergoing a universal glycation
procedure (Schiff’s base reactions between the sugar and the
protein, followed by conversion to ketoamines through Amadori
rearrangement, and finally formation of AGEs), different proteins
show different conformational changes during ribosylation.
Ribosylated a-Syn Has High Cytotoxicity
In this research we have studied a-Syn glycation in the presence
of D-glucose. As mentioned above, the cytotoxicity of ribosylated
a-Syn was much higher than that of glucosylated a-Syn under our
experimental conditions. This is consistent with results obtained
previously for the glycation of BSA and Tau protein, an important
protein involved in Alzheimer’s disease which causes impairments
of cells [31,32].
This work has showed that ribosylated a-Syn is able to
significantly inhibit the growth of SHSY5Y cells (Fig. 10). The
dose-dependent cytotoxicity observed here reveals that glycated a-
Syn may disturb neural cell metabolism and viability. Results from
the flow cytometric analysis of annexin V/PI support this
Figure 9. Changes in the fluorescence of thioflavin T and light
scattering in the presence of ribosylated a-Syn at different
time intervals. (A) ThT (30 mM) was added to samples of a-Syn in
different concentrations of D-ribose for different time intervals. The
intensity of ThT fluorescence was recorded (lex 450 nm; lem 485 nm).
The kinetics of the increase in the fluorescence emission of ThT with
glycated a-Syn is shown. (B) Aliquots were taken for measurements of
the intensity of scattered light (lex 480 nm; lem 480 nm) under the
same conditions. Native a-Syn alone was used as a control.
doi:10.1371/journal.pone.0009052.g009
Figure 10. Cell viability was measured with the MTT assay. Cell
viability of SHSY5Y cells was measured after adding 3.5 mM, 35 mM and
140 mM ribosylated a-Syn at 24 h (A), 48 h (B) and 72 h (C).
doi:10.1371/journal.pone.0009052.g010
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was induced by ribosylated a-Syn. Nie and colleagues have
reported that formaldehyde-treated globular aggregates of Tau
possess cytotoxicity [33]. Similarly, soluble ThT-positive molten
globules of ribosylated a-Syn also have the ability to promote
SHSY5Y cell death. Thus, molten globules of ribosylated a-Syn
may be useful as a molecular model for simulating protein
misfolding in vitro. In the light of its high cytotoxicity, it appears
that ribosylation may play an important role in a-Syn pathological
processes.
AGE-recombinant Tau generates reactive oxygen intermediates
and induces oxidative stress when introduced into the cytoplasm of
SHSY5Y neuroblastoma cells [56]. In a previous report we have
shown that apoptosis induced by ribosylated BSA and Tau is
involved in oxidative stress [31]. It appears that the oxidative
signaling pathway is at least involved in the cell death induced by
the ribosylated a-Syn protein.
Glycated a-Syn Has Been Found in the Brain Tissues of
PD Patients, Especially in the Lewy Bodies
It has been reported that glycated a-Syn is found in the brain of
patients with PD [9]. Many research groups have studied the
relationship between glycation of a-Syn protein and the formation
of LB [12]. Furthermore, glycated a-Syn induces lipid peroxida-
tion in vivo and results in lesions within cells [13]. This suggests that
glycation may play a role in stabilizing the a-Syn aggregations that
are related to LB formation in PD [9]. Although glycated a-Syn
protein has been found in LB, it has been difficult to clarify
whether the bound sugar is D-ribose or D-glucose. This question
needs further investigation.
Figure 11. Ribosylated a-Syn induces SH-SY5Y cell apoptosis. SH-SY5Y cells were treated with ribosylated a-Syn for 8 h and then cultured for
24 h, before analysis by flow cytometry (D). Normal cells were used as controls (A), cells incubated with D-ribose (B) and a-Syn (C) are shown.
doi:10.1371/journal.pone.0009052.g011
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molten globules which induce SHSY5Y cell death by cell oxidative
stress. These molten globules of ribosylated protein have some
similar characteristics to pathological aggregations in their high
cytotoxicity and could thus be used as an in vitro model for research
to identify drugs that are valuable for disease treatment, such as
the ‘‘anti-glycation’’ treatment for PD and other neurodegenera-
tive diseases [63].
Materials and Methods
Expression and Purification of a-Syn
Human wild type a-Syn was expressed in Escherichia coli
BL21(DE3) cells using a pRK172-a-Syn plasmid (a kind gift from
Dr. Hongyu Hu, Institute of Biochemistry and Cell Biology,
Shanghai Institutes for Biological Sciences, China) and purified as
described by Huang et al [64]. The resultant a-Syn was present as
a single band on SDS-PAGE with a purity of ,95% as shown in
Fig. S1. The purified a-Syn was lyophilized and stored at -70uC
before use.
Preparation of Ribosylated Protein
a-Syn was dissolved in 20 mM Tris-HCl (pH 7.4) to yield a
stock solution of 20 mg/ml. This solution was then resuspended
with D-ribose (Sigma, USA) prepared in Tris-HCl (pH 7.4) to a
final concentration of 10 mg/ml a-Syn and 1 M monosaccharide.
a-Syn alone and in the presence of D-glucose (Sigma, USA) were
used as controls. Reaction mixtures were incubated at 37uC for
different lengths of time (from 0 to 7 days). All solutions were
filtered with 0.22 mm membranes (Millipore, USA).
NBT Colorimetric Fructosamine Assay
The extent of glycation of individual a-Syn preparations was
assessed using the NBT (Ameresco, USA) assay as described
previously [17,37,65,66]. 200 ml of 0.75 mM NBT was added to a
96-well microplate along with 10 ml of the sample or standard.
The kinetics of the reduction of NBT by the fructosamine group
(0.1 M carbonate buffer, pH 10.35) were measured at 540 nm
after incubation for 30 min at 37uC using an MK3 microplate
reader (Thermo, USA). Standard curves were generated by
addition of 10 ml of 1-deoxy-1-morpholino-D-fructose (1-DMF,
Sigma-Aldrich, USA). The quantity of fructosamine formed was
established by comparing with standard curves (R
2.0.99).
SDS-PAGE
Aliquots of glycated protein samples were subjected to SDS-
PAGE. For the digestion experiment, a-Syn (35 mM) and trypsin
(3.5 mM) were mixed in Tris-HCl buffer (pH 7.4) to give a final
Figure 12. LDH assay and measurement of reactive oxygen
species in SH-SY5Y cells. (A) LDH activity was measured using a
cytotoxicity detection kit (Roche, Switzerland). (B) The levels of reactive
oxygen species in cells treated with glycated a-Syn for 24 h were
measured. Cells treated with a-Syn, D-ribose and a blank were used as
controls.
doi:10.1371/journal.pone.0009052.g012
Figure 13. A putative scheme for the aggregation of ribosy-
lated a-Syn protein into highly cytotoxic molten globules.
doi:10.1371/journal.pone.0009052.g013
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subjected to electrophoresis using Bio-Rad (USA) electrophoretic
equipment.
Western Blotting
Aliquots of a-Syn incubated with D-ribose for different
durations were subjected to electrophoresis. The proteins were
then transferred onto PVDF membranes, and probed with anti-
AGEs (dilution=1:1000, 6D12, Wako, Osaka, Japan) followed by
goat anti-mouse horseradish peroxidase (HRP) (KPL, Gaithers-
burg, Maryland, USA) at a dilution of 1:2000. Immunoreactive
bands were visualized using enhanced chemiluminescence (Pierce,
USA).
Fluorescence Measurements
Intrinsic fluorescence of a-Syn (5 mM) was monitored on an
F4500 fluorescence spectrophotometer (Hitachi, Japan). The
emission spectrum from 290 nm to 500 nm was recorded by
excitation at 280 nm at 25uC. To measure the energy transfer
from the intrinsic fluorescence (tyrosinyl residues) to ribosylated
fluorescent derivatives, glycated aliquots were excited at 280 nm
and the emission spectra from 300 nm to 500 nm was recorded.
To assess the fluorescence of AGEs derived from glycated protein,
we monitored an emission spectrum from 320 nm to 500 nm
(lex=320 nm) as described previously [67].
Measurement of Thioflavin T Binding Fluorescence
a-Syn (5 mM) and thioflavin T (30 mM, Sigma, USA) were
mixed at 25uC, and the fluorescence was subsequently measured
(lex450 nm; lem485 nm) as described [68].
ANS Binding Assay
A stock solution of 3.3 mM ANS (Sigma, USA) was prepared in
20 mM Tris-HCl (pH 7.4). a-Syn (7 mM) and ANS (70 mM,
Sigma-Aldrich, USA) were mixed at room temperature for 1 h,
and the fluorescence was subsequently measured by recording the
emission spectrum from 400 to 600 nm (lex=350 nm).
Light-Scattering Assay
In light scattering experiments the intensity of scattered light
from ribosylated a-Syn (5 mM) was recorded using a F4500
fluorescence spectrofluorometer, whose incident and scattering
monochromators were both set at 480 nm. a-Syn protein alone
was used as a control.
Observation with Atomic Force Microscopy
The conditions for producing ribosylated a-Syn were as
described above. All solutions used were filtered through a
0.22 mm filter. Samples were diluted to the desired concentration
using Tris-HCl buffer (pH 7.4), and aliquots (10 ml) were allowed
to adsorb onto the mica and were kept at room temperature for 5
min before observation. Observation under AFM (Mutiplemode-I,
Digital Instruments, USA) was carried out as described previously
[68].
Circular Dichroism (CD) Spectropolarimetry
Measurements
Far-UV CD measurements were performed on a circular
dichroism chiroptical spectrometer (Jasco J-720, Japan). Samples
in a 1 mm quartz cuvette were maintained at 25uC with a
circulating water bath. The spectra of ribosylated a-Syn (50 mM)
were measured (195 nm–260 nm) with a step size of 1.0 nm. Each
measurement was repeated 10 times and averaged. The
background of the corresponding buffers in the absence of protein
and D-ribose was subtracted for all the samples.
Cell Culture in the Presence of Ribosylated a-Syn
SHSY5Y cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Gibco, USA) containing 10% fetal bovine
serum (Hyclone, USA), 100 IU/ml penicillin and 100 mg/ml
streptomycin (Sigma, USA) at 37uC in a humidified 5% CO2
incubator. Cells were grown to 70–80% confluence in 25 mm
diameter dishes and subcultured every fourth day. To test the
effect of ribosylated a-Syn on cell growth, the culture medium was
replaced with serum-free medium before the addition of the
glycated protein. The cells were incubated with different
concentrations of ribosylated a-Syn (3.5 mM and 35 mM) for 8
h, after which the medium was changed to DMEM with 10% fetal
bovine serum for further culture.
Cell Viability Test
We used a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT, Sigma) test, which was slightly
modified from that of Mayo and Stein [69]. SHSY5Y cells were
seeded onto a 96-well plate at a concentration of 10
5 cells per well
and either exposed or not exposed to ribosylated a-Syn for 8 h.
MTT (0.5 mg/ml) was added after 24, 48, or 72 h and incubated
at 37uC for 4 h. The reaction was terminated by replacing the
MTT-containing medium with 150 ml dimethysulfoxide, and
absorbance at 540 nm was measured on a Multiscan Mk3
spectrophotometer (Thermo Electron Corporation, USA).
Cytotoxicity Detection
LDH cytotoxicity assays were performed according to the
manufacturer’s protocol (Roche, Switzerland). This colorimetric
assay quantifies activity of LDH released from the cytosol of
damaged cells into the supernatant and thus serves to quantify cell
death [70,71].
Measurement of Intracellular ROS
Levels of cytosolic ROS were measured by 29,79-dichlorofluor-
escein-diacetate (DCFH-DA, Beyotime, China) as described [72].
SH-SY5Y cells were grown in a 24-well plate and incubated with
ribosylated a-Syn for 8 h. Cells in the presence and absence of D-
ribose and native a-Syn were used as controls. Cells were washed
with PBS and incubated with DCFH-DA for 30 min. DCFH-DA
was initially non-fluorescent and was converted by oxidation to the
fluorescent molecule DCFH (lex485 nm; lem538 nm). DCFH was
then quantified using a CytoFluor Multi-well Plate Reader
(Fluoroskan Ascent, Thermo Lab Systerms, USA).
Flow Cytometry
Cells undergoing apoptosis were detected by double staining with
annexin V-FITC/PI in the dark according to the manufacturer’s
instructions [73]. Cells attached to dishes were harvested with
0.25% trypsin and washed twice with cold PBS. Cell pellets were
suspended in 16binding buffer (10 mM HEPES/NaOH, pH 7.4,
140 mM NaCl, 2.5 mM CaCl2) at a concentration of 1610
6 cells/
ml, and then incubated with annexin V- FITC and propidium
iodide (PI) for 15 min (22–25uC) in the dark. The stained cells were
immediately analyzed by flow cytometry (FAC Svantage SE, USA).
Each measurement was carried out at least three times.
Data Analysis
All values reported are means 6 standard errors (SE), except
where otherwise indicated. Data were analyzed with Origin 6.0
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between experimental groups were considered to be significant if
the probability was ,0.05 in two-tailed tests. Analysis of first order
rate constants in the kinetic studies were as described by Tsou
[74].
Supporting Information
Figure S1 Purification of a-Syn. A culture overexpressing a-Syn
was induced with 200 mM IPTG for 3 h (lane 1, 2 and 3). After
disrupting the cell by osmotic shock (lane 4), the pellet was
resuspended in periplasm protein extraction buffer (lane 5). Then
the supernatant was collected and purified by Q-sepharose FF
(lane 6, 7) and Superdex 75 (lane 9) column. All samples were
analysed by 15% SDS-PAGE.
Found at: doi:10.1371/journal.pone.0009052.s001 (0.38 MB TIF)
Figure S2 N-terminal sequencing of ribosyled a-Syn digested by
trypsin. The experiment conditions were the same as those in
Fig. 5A. Aliquots were taken from the incubation at day 3,
followed by band ‘a’ (A) and band ‘b’ (B) on gel were sequenced as
described [75].
Found at: doi:10.1371/journal.pone.0009052.s002 (0.15 MB PPT)
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